Skip to content

Clinical trials

Neurocognitive Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurocognitive Disorders Country / region: United States Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20111
20123
20132
20142
20153
20162
20178
20186
20195
20206
20215
20225
20239
20244
20255
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Recruiting14
Terminated13
Active, not recruiting4
Enrolling by invitation3
Unknown status3
No longer available1
Not yet recruiting1
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Michigan4
University of Pennsylvania4
Alkahest, Inc.3
Eli Lilly and Company3
AstraZeneca2
Johns Hopkins University2
MapLight Therapeutics2
Medical University of South Carolina2
New York State Psychiatric Institute2
University of California, Los Angeles2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurocognitive Disorders75
Dementia36
Alzheimer Disease34
Cognitive Dysfunction29
Brain Diseases23
Mental Disorders23
Neurodegenerative Diseases23
Central Nervous System Diseases22
Nervous System Diseases22
Tauopathies14

Trials

Showing 26 to 50 of 75. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.